Ceftriaxon MIP 1 g Norge - norsk - Statens legemiddelverk

ceftriaxon mip 1 g

mip pharma gmbh - ceftriaksonnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g

Plenvu Norge - norsk - Statens legemiddelverk

plenvu

norgine b.v. - makrogol 3350 / natriumaskorbat / natriumsulfat, vannfritt / askorbinsyre / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 140 g / 48.11 g / 9 g / 7.54 g / 5.2 g / 2.2 g

Rhokiinsa Den europeiske union - norsk - EMA (European Medicines Agency)

rhokiinsa

santen oy - netarsudil - glaucoma, open-angle; ocular hypertension - Øyemidler - reduksjon av forhøyet intraokulært trykk (iop) hos voksne pasienter med primær åpenvinkelglaukom eller okulær hypertensjon.

Roclanda Den europeiske union - norsk - EMA (European Medicines Agency)

roclanda

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - Øyemidler - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

Allopurinol Aristo 300 mg Norge - norsk - Statens legemiddelverk

allopurinol aristo 300 mg

aristo pharma gmbh - allopurinol - tablett - 300 mg

Allopurinol Aristo 100 mg Norge - norsk - Statens legemiddelverk

allopurinol aristo 100 mg

aristo pharma gmbh - allopurinol - tablett - 100 mg

Dimethyl fumarate Neuraxpharm Den europeiske union - norsk - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Enjaymo Den europeiske union - norsk - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunsuppressive - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Elfabrio Den europeiske union - norsk - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sykdom - andre alimentary tract and metabolism products, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Hyftor Den europeiske union - norsk - EMA (European Medicines Agency)

hyftor

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.